Progenika Biopharma SA creates a subsidiary in the UK
Progenika Ltd will provide a diagnostic service based on the unique Sendagene(TM) platform for the diagnosis of genetically complex diseases. Dr Laureano Simon, company founder and CEO, underlined the enormous potential of the Sendagene(TM) technology for the early diagnosis of potentially debilitating conditions allowing doctors to treat and control important diseases suffered by their patients such as Familial Hypercholesterolaemia and Inflammatory Bowel Disease. The creation of Progenika Biopharma Ltd brings the possibility of individualized medicine one step closer to reality he said in a statement today.
Topics
Organizations
Other news from the department manufacturing
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.